Latest Breaking News On - Nct02872116 - Page 1 : comparemela.com

Kohei Shitara, MD, discusses 4-year survival data of chemotherapy plus nivolumab in advanced gastric/GEJ cancer or esophageal adenocarcinoma.

United statesKohei shitaraCancers symposiumGastrointestinal oncologyNational cancer center hospital eastPhase 3 checkmate 649 studyAdvanced gastric cancerAstroesophageal junction gej cancerR esophageal adenocarcinoma